Sort
51,593 grants matching “hepatitis”
Caribbean, Central and South America network for HIV epidemiology (CCASnet)
$2,276,696Catherine C McGowan · Vanderbilt University · U01 · FY2014 · AI
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$2,276,671Mark Fredric Cotton · Stellenbosch University · UM1 · FY2020 · AI
North American AIDS Cohorts on Collaboration and Design (NAACCORD)
$2,276,122Richard Douglas Moore · Johns Hopkins University · U01 · FY2011 · AI
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,275,700Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,275,700Hanno Steen · Boston Children'S Hospital · U19 · FY2021 · AI
COBRE Center for Cancer Research Development
$2,274,718Douglas C Hixson · Rhode Island Hospital · P20 · FY2010 · RR
Hepatobiology and Toxicology COBRE
$2,274,291Craig J McClain · University Of Louisville · P20 · FY2023 · GM
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,272,798Steven Foung · Stanford University · U19 · FY2024 · AI
The Military HIV Research Program (MHRP) Clinical Trial Unit
$2,272,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2021 · AI
Molecular Biology and Genetics of Human Tumor Viruses
$2,272,641Paul F Lambert · University Of Wisconsin-Madison · P01 · FY2021 · CA
Non-alcoholic Fatty Liver Disease and Cardiovascular Disease in Hispanics/Latinos
$2,271,824Jorge R Kizer · Northern California Institute/Res/Edu · R01 · FY2022 · HL
Immunotherapy of low grade lymphoid malignancies
$2,271,399Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Health Economics of Substance Use Disorder, HCV, and HIV Treatment: Supporting Financial Sustainability, Advanced Methods, and Knowledge Translation
$2,270,589Bruce R Schackman · Weill Medical Coll Of Cornell Univ · P30 · FY2025 · DA
Adeno-associated Virus Biology And Utilization For Gene Transfer
$2,269,320John A Chiorini · National Institute Of Dental & Craniofacial Research · ZIA · FY2016 · DE
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,268,699Steven Foung · Stanford University · U19 · FY2025 · AI
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$2,268,135Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
(HVTN) HIV VACCINE TRIAL UNITS
$2,267,098Johns Hopkins University · U01 · FY2000 · AI
Establishment of a Bat Resource for Infectious Disease Research
$2,266,918William A Schountz · Colorado State University · R24 · FY2024 · AI
Immune Pathophysiology of Aplastic Anemia and Immunosuppressive Treatments
$2,265,937Neal S Young · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Novel commensal polysaccharide treats multiple sclerosis through Treg modulation
$2,264,726Lloyd H Kasper · Symbiotix Biotherapies, Inc. · R42 · FY2015 · AI
The Johns Hopkins University - Uganda Clinical Trials Unit
$2,263,627Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2023 · AI
SCORE Program at New Mexico State University, Las Cruces
$2,263,591New Mexico State University Las Cruces · S06 · FY2005 · GM
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,263,268Sallie R. Permar · Duke University · P01 · FY2017 · AI
Translational Multimodality " Antibody" Therapy
$2,262,864Gerald L Denardo · University Of California At Davis · P01 · FY2006 · CA
HIV Neurobehavioral Research Center
$2,261,800Igor Grant · University Of California, San Diego · P30 · FY2007 · MH